Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 1, 2003, Pages 289-292

  Bischof, Marc ^a   Huber, Peter ^a   Stoffregen, Clemens ^a   Wannenmacher, Michael ^a   Weber, Klaus Josef ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alimta; Cell cycle; Multitargeted antifolate; Pemetrexed; Radiation

Indexed keywords

CELLS; CLONING; DNA; METABOLITES;

ANTIMETABOLITE;

CARCINOGENS;

PEMETREXED;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCULATION; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL KILLING; CLONOGENIC ASSAY; COLON CARCINOMA; CONTROLLED STUDY; DRUG EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RADIOSENSITIZATION; SURVIVAL RATE;

EID: 0041563977     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00595-9     Document Type: Article

References (15)

1. Hanauske A.R., Chen V., Paoletti P., et al. Pemtrexed disodium A novel antifolate clinically active against multiple solid tumors . Oncologist. 6:2001;363-373.
2. Chen V.J., Bewley J.R., Gossett L., et al. Activity of LY231514 against several enzymes in the folate-dependent pathways. (Abstr) Proc Am Assoc Cancer Res. 37:1996;A2598.
3. Mendelsohn L.G., Shih C., Chen V.J. Enzyme inhibition, polyglutamation and the effect of LY231514 (MTA) on purine biosynthesis. Semin Oncol. 26:(Suppl. 6):1999;42-47.
4. Bischof M., Weber K.J., Blatter J., et al. Interaction of pemetrexed disodium (Alimta, multi targeted antifolate) and irradiation in vitro. Int J Radiat Oncol Biol Phys. 52:2002;1381-1388.
5. Nicoletti I., Migliorati G., Pagliacci M.C., et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 139:1991;271-279.
6. Schäfer J., Bachtler J., Engling A., et al. Suppression of apoptosis and clonogenic survival in irradiated human lymphoblasts with different TP53 status. Radiat Res. 158:2002;699-706.
7. Buchholz D.J., Lepek K.J., Rich T.A., et al. 5-fluorouracil-radiation interactions in human colon adenocarcinoma cells. Int J Radiat Oncol Biol Phys. 32:1995;1053-1058.
8. Latz D., Fleckenstein K., Eble M., et al. Radiosensitizing potential of Gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys. 41:1998;875-882.
9. Iliakis G. Radiation-induced potentially lethal damage DNA lesions susceptible to fixation . Int J Radiat Oncol Biol Phys. 53:1988;541-548.
10. Lee S.E., Mitchell R.A., Cheng A., et al. Evidence for DNA PK-dependent and -independent DNA double-strand repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol. 17:1997;1425-1433.
11. Karran P. DNA double-strand break repair in mammalian cells. Curr Opin Genet Dev. 10:2000;144-150.
12. Rodrigues N.R., Rowan A., Smith M.E., et al. P53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 87:1990;7555-7559.
13. Olive P.L., Durand R.E. Apoptosis An indicator of radiosensitivity in vitro? Int J Radiat Biol. 71:1997;695-707.
14. Hendry J.H., West C.M. Apoptosis and mitotic cell death Their relative contributions to normal-tissue and tumour radiation response . Int J Radiat Biol. 71:1997;709-719.
15. Tonkinson J.L., Marder P., Andis S.L., et al. Cell cycle effects of antifolate antimetabolites Implications for cytotoxicity and cytostasis . Cancer Chemother Pharmacol. 39:1997;521-531.